Suzhou Highfine Biotech Co Ltd (SZSE:301393) Share Price

Company Profile

Business description
Suzhou Highfine Biotech Co Ltd is a high-tech enterprise that provides characteristic raw materials for global pharmaceutical research and development and raw material drug production companies. The products are mainly used in the fields of peptide, nucleotide and pharmaceutical synthesis. The product range covers peptide synthesis reagents for characteristic amide bond formation, molecular building blocks, protein reagents, liposome and lipid nanoparticle pharmaceutical reagents, ionic liquids , PROTAC reagents and nucleotide reagents and other types.
Contact
No. 32 Hongxi Road
F-12 Standard Factory Building
High-tech Zone, Jiangsu Province
Suzhou215151
CHN
T: +86 51265399366
https://www.highfine.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
678

Recommended

A well-timed simplification journey as boring evolves back in vogue.

Brian Han | 20 April 2026

Passive income growth continues to exceed my target.

Mark LaMonica, CFA | 20 April 2026

Shares surged after the announcement of first half fiscal 2026 guidance.

Mark Taylor | 17 April 2026

Index	Last price	Change	% Change
All Ordinaries	9,168.70	33.00	0.36%
CAC 40	8,425.13	0.00	0.00%
DAX 40	24,702.24	547.77	2.27%
Dow JONES (US)	49,447.43	868.71	1.79%
FTSE 100	10,667.63	77.64	0.73%
HKSE	26,160.33	233.93	-0.89%
NASDAQ	24,468.48	365.78	1.52%
Nikkei 225	58,475.90	1,042.44	-1.75%
NZX 50 Index	12,905.67	160.39	-1.23%
S&P 500	7,126.06	84.78	1.20%
S&P/ASX 200	8,946.90	36.80	0.41%
SSE Composite Index	4,051.43	4.12	-0.10%